focus -WSS

focus

author：hotspot 2025-09-28 23:48:52 - browse：599

The FDA building -- First Opinion coverage from STAT — Adobe

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday.

Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS, which is one of the most common genetic mutations in cancer.

The vote comes as Amgen is hoping to convert a conditional approval for the drug to a full approval based on a 345-person study called CodeBreaK 200, in which Lumakras met the primary endpoint, delaying tumor growth approximately five weeks longer than the standard of care medication, docetaxel. The drug didn’t extend patients’ overall survival.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Malaria cases in Florida and Texas: Here’s what you need to know

WSS

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Apple is now the first public company to be valued at $3 trillion

Moonlake's readout produced a cash windfall. Risks remain

Britney Spears to release memoir, 'The Woman In Me,' later this year

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Virginia high school admissions case could be legal follow

explore

focus

hotspot

Guidelines to prevent youth baseball injuries need more muscle

A Greenpeace activist is fined for crash

What does generative AI mean for health care? We asked experts

Hepatitis C has a cure — but many Americans still lack access to it

United colonoscopy coverage change 'may cost lives,' doctors say

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bright Health sells Medicare Advantage business to Molina

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Peter Hotez and the public health issue of online harassment

Digital health funding stays low as a new reality sets in

focus

New air purifier tech could be key to improving indoor air quality

Alkermes shareholders re

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

United colonoscopy coverage change 'may cost lives,' doctors say

United colonoscopy coverage change 'may cost lives,' doctors say

Affirmative action in medical school literally saved lives

hotspot

entertainment

focus

explore